Share:
near term COVID-19 vaccination allocations to follow
TORONTO, May 17, 2021 (GLOBE NEWSWIRE)
Medivolve Inc. ( Medivolve ) ((NEO:MEDV, OTC:COPRF, FRA:4NC)) a healthcare technology and services company, today announced it has signed a binding agreement to acquire 100% of all outstanding shares of Marbella, a nonsterile compounded California state licensed and insured pharmacy. This acquisition advances Medivolve s growth strategy and expands its ability to deliver patient care through immediate access to pharmaceutical distribution throughout the state of California. The acquisition of Marbella Pharmacy is an important step forward in executing on our strategic growth strategy, said David Preiner, CEO of Medivolve. With Marbella, we have access to distribute pharmaceuticals, and soon COVID-19 vaccinations in the fifth-largest economy in the world. We will continue to invest in the resources and partnerships that advance our mission to harness the transformative power